Willow Bioscience files patent to help reduce costs of corticosteroids

About this update from Atlas Energy Corp.

[{"type":"text","content":"Willow Bioscience files patent to help reduce costs of corticosteroids\n \n \n (NewsDirect)\n \n \n \n \n Willow Bioscience CEO Dr Chris Savile\njoined Steve Darling from Proactive to announce a groundbreaking\ndevelopment in the pharmaceutical industry.\n \n \n Savile shared the company's\nachievement in creating a cost-effective process for producing\ncorticosteroids using their innovative BioOxi platform. This novel\napproach to efficient bio-hydroxylation has the potential to\nrevolutionize corticosteroid manufacturing.\n \n \n Corticosteroids are widely used for their\nanti-inflammatory and immunosuppressant properties, making them\nessential drugs in medical practice. With the corticosteroid market\nprojected to grow to $5.93 billion by 2026, ensuring a stable supply\nchain is crucial. However, a significant portion of corticosteroid\nproduction occurs outside the United States, leading to potential\nsupply chain vulnerabilities and shortages for drug manufacturers.\n \n \n Savile explained that Willow\nBioscience's BioOxi process represents a significant advancement\nby substantially reducing the production costs of corticosteroids.\nThis breakthrough is anticipated to make domestic manufacturing more\ncompetitive, encouraging the onshoring of corticosteroid production\nand reducing supply chain risks.\n \n \n If\ngranted, the patent protection for this process could offer a\nremarkable competitive advantage to pharmaceutical manufacturing\npartners.\n \n \n The development of a\ncost-effective corticosteroid manufacturing process highlights Willow\nBioscience's commitment to innovation and addressing critical\nchallenges in the pharmaceutical industry. By leveraging its BioOxi\nplatform, the company is not only transforming manufacturing practices\nbut also contributing to the security and availability of essential\nmedications for patients worldwide.\n \n \n \n Contact\nDetails\n \n \n \n Proactive Investors\n \n \n +1 604-688-8158\n \n \n \n [email protected]\n \n \n \n Copyright (c) 2023 TheNewswire - All rights reserved.\n \n \n","length":2569,"tagName":"div"}]

More updates from Atlas Energy Corp.